Search results
Director, Center for Chemical Biology & Translational Medicine. Lieberman studies how certain viruses establish a long-term latent infection that can lead to cancer or autoimmune disorders. Lieberman joined The Wistar Institute in 1995 as an assistant professor.
Paul M. Lieberman is an American biomedical researcher and chairperson of the Gene Expression and Regulation Program at the Ellen and Ronald Caplan Cancer Center at The Wistar Institute in Philadelphia.
Oct 28, 2021 · Paul M Lieberman. Wistar Institute Professor of Microbiology. Department: Microbiology. Contact information. The Wistar Institute. Dept of Molecular Genetics, Rm 201. 3601 Spruce St. Philadelphia, PA 19104-4265. Office: 215 898-9491. Fax: 215 898-0663. Email: lieberman@wistar.org. Publications. Search PubMed for articles. Links.
Oct 28, 2021 · Description of Research Expertise. Genome maintenance and gene expression; Gammaherpesviruses and oncogenesis; Telomere Biology, Chromatin structure and genome stability; Transcription regulation. Key words: viral latency, telomeres, chromatin, DNA replication, transcription regulation, herpesvirus.
Jul 29, 2020 · Dr. Paul Lieberman is a molecular virologist in Wistar’s Cancer Center, better known for his pioneering studies on how certain viruses persist in the body in a latent, long-term infection that can lead to cancer.
Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus latency by virus-encoded microRNAs that target Rta and the cellular Rbl2-DNMT pathway. F Lu, W Stedman, M Yousef, R Renne, PM...
Paul Lieberman, Ph.D., has developed a small molecule inhibitor of the EBV protein EBNA1 for EBV-associated malignancies. Preclinical development of this compound was largely supported by Wellcome, a biomedical research charity based in the United Kingdom.
